Dihydrofolate Reductase Is a Valid Target for Antifungal Development in the Human Pathogen <italic toggle="yes">Candida albicans</italic>
ABSTRACT While the folate biosynthetic pathway has provided a rich source of antibacterial, antiprotozoal, and anticancer therapies, it has not yet been exploited to develop uniquely antifungal agents. Although there have been attempts to develop fungal-specific inhibitors of dihydrofolate reductase...
Guardado en:
Autores principales: | Christian DeJarnette, Arturo Luna-Tapia, Leanna R. Estredge, Glen E. Palmer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7bedfb15049f4488a03cf31477b69091 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The antifungal effect of six commercial extracts of Chilean propolis on Candida spp
por: Herrera,Christian L, et al.
Publicado: (2010) -
Dihydrofolate Reductase Inhibitors: The Pharmacophore as a Guide for Co-Crystal Screening
por: João A. Baptista, et al.
Publicado: (2021) -
Target Abundance-Based Fitness Screening (TAFiS) Facilitates Rapid Identification of Target-Specific and Physiologically Active Chemical Probes
por: Arielle Butts, et al.
Publicado: (2017) -
Molecular Elucidation of Riboflavin Production and Regulation in <named-content content-type="genus-species">Candida albicans</named-content>, toward a Novel Antifungal Drug Target
por: Liesbeth Demuyser, et al.
Publicado: (2020) -
Oxadiazole-Containing Macrocyclic Peptides Potentiate Azole Activity against Pathogenic <italic toggle="yes">Candida</italic> Species
por: Nicole M. Revie, et al.
Publicado: (2020)